Search Tips
of 1 Next >
Results Found: 2
  • Mll3 suppresses tumorigenesis by activating the Ink4a/Arf locus

    Authors
    Soto-Feliciano, Yadira M.
    Zhu, Changyu
    Morris IV, John P.
    Huang, Chun-Hao
    13 more author(s)...
    Description

    Summary from Dryad: "Abstract: Mutations in genes encoding components of chromatin modifying and remodeling complexes are among the most frequently observed somatic events in human cancers. For example, missense and nonsense mutations targeting the mixed lineage leukemia family member 3 (MLL3/KMT2C) histone methyltransferase occur in a range of solid tumors and heterozygous deletions encompassing...

    Subject
    Carcinogenesis/genetics
    Carcinoma, Hepatocellular
    Cyclin-Dependent Kinase Inhibitor p16
    Leukemia
    Tumor Suppressor Protein p14ARF
    Access Rights
    Free to All
  • Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway Specific MHC ligands as Potential Targets for Cancer Immunotherapy

    Authors
    Klatt, Martin Gunther
    Scheinberg, David A.
    Description

    Description from PRIDE: "Cyclin dependent kinase 4/6 inhibitors (CDK4/6i) lead to cell-cycle arrest but also trigger T cell-mediated immunity, which might be mediated by the qualitative and quantitative changes in human leukocyte antigen (HLA) ligands on the cancer cell surface. We investigated the effects of CDK4/6i, Abemaciclib and Palbociclib, on the immunopeptidome at subclinical, non-toxic,...

    Subject
    Breast Neoplasms
    Cyclin-Dependent Kinase 4
    Cyclin-Dependent Kinase 6
    Cyclin-Dependent Kinase Inhibitor p16
    Cyclin-Dependent Kinase Inhibitor p18
    HLA Antigens
    T-Lymphocytes
    Access Rights
    Free to All